PP
AGN

Palladium Partners’s Allergan plc AGN Stock Holding History

Palladium Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,769
Closed -$1.39M – 264
2017
Q3 		$1.39M Sell
6,769
-24,392
-78% -$5.67M 0.11% 131
2017
Q2 		$7.58M Buy
31,161
+523
+2% +$123K 0.6% 47
2017
Q1 		$7.32M Buy
30,638
+1,722
+6% +$401K 0.59% 51
2016
Q4 		$6.07M Sell
28,916
-5,556
-16% -$1.15M 0.51% 58
2016
Q3 		$7.94M Buy
34,472
+1,368
+4% +$334K 0.69% 45
2016
Q2 		$7.65M Buy
33,104
+2,730
+9% +$629K 0.7% 45
2016
Q1 		$8.14M Sell
30,374
-986
-3% -$282K 0.75% 44
2015
Q4 		$9.8M Buy
31,360
+754
+2% +$224K 0.91% 37
2015
Q3 		$8.32M Buy
30,606
+3,886
+15% +$1.19M 0.82% 37
2015
Q2 		$8.11M Buy
26,720
+1,362
+5% +$406K 0.72% 41
2015
Q1 		$7.55M Buy
25,358
+6,773
+36% +$1.93M 0.65% 51
2014
Q4 		$4.78M Buy
+18,585
New +$4.65M 0.42% 72
2014
Q2 		– Sell
-400
Closed -$82K – 488
2014
Q1 		$82K Buy
+400
New +$79.2K 0.01% 305
2013
Q4 		– Sell
-400
Closed -$58K – 501
2013
Q3 		$58K Hold
400
– – 0.01% 331
2013
Q2 		$50K Buy
+400
New +$45.3K 0.01% 341

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Palladium Partners's AGN Position: Q4 2017 in Review

Palladium Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 6,769 shares — an estimated $1.39M sold.

Palladium Partners first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $9.8M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Palladium Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Palladium Partners sold 6,769 Allergan plc shares in Q4 2017, an estimated $1.39M.
  • Palladium Partners first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • Palladium Partners's Allergan plc position peaked at $9.8M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Palladium Partners's 13F filing for Q4 2017, filed 5 Feb 2018.